New US Patent Issued to Immunitor on Oral Vaccine Technology

Immune Network Ltd., (IMMFF:PK), reports that the United States Patent and Trademark Office has granted US Patent No. 7,914,799 for composition and methods relating to the platform technology of its main business. Vancouver, BC, Canada (PRWEB) October 14, 2011 Issued patent reinforces the premises of an earlier patent No. 7,827,099 received in November of last year. 'We concur with the USPTO that the subject matter covered by this patent is unique and worthy of patent protection' said Dr. Aldar Bourinbaiar, co-founder of Immunitor and thirty year veteran in the vaccine industry. The newly
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations